Inovio Pharmaceuticals Ceo Navy Seal Of Cancer Fighting Mad Money Cnbc

Summary

The under-the-radar biotech that roared more than 20 percent Monday on a big deal with AstraZeneca. Is there more room to run? It is a company with a breakthrough therapy that wants to hack your DNA to battle Carrizo Oil & Gas has been drilling into some of the country's biggest finds for over a decade and owning its shares has given you ... "We expect to finish enrollment of all 40 volunteers before the end of April," Jim Cramer spoke with Halozyme's Ingevity was considered one of the top spinoffs of 2016, and its A biotech with a life changing test. It's up 186% so far this year and still managed to surge 15% this week. Jim Cramer sat down ... The stock has lost some altitude over the past few weeks , it's still up big. Time to buy, or jump ship? » to With a host of new drugs in development, and a skyrocketing stock, can it keep going higher? » to This biotech has tripled in value in the past year, and Jim Cramer sees plenty of value in the pipeline ahead. » to ... Have real estate investment trust stocks been overlooked due to fears of the Fed? Jim Cramer finds out what could be in store for ... It's a little known biotech company with a new way to treat